SARAH CHAMBERS: Open Payments
NPI 1639663966 · CORTLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,375 in 66 payments from 11 companies in 2025. Trend: 2023 $1,471 · 2024 $1,612 · 2025 $1,375
Food & beverage: $1,270Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $284 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $280 |
| Teva Pharmaceuticals USA, Inc. | 12 | $219 |
| Otsuka America Pharmaceutical, Inc. | 10 | $186 |
| E.R. Squibb & Sons, L.L.C. | 12 | $172 |
| Neurocrine BioSciences, Inc. | 2 | $119 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Braeburn Inc. | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, COBENFY, INGREZZA, ABILIFY ASIMTUFII, UZEDY, REXULTI, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
